Lignins and their close derivatives produced by biorefinery processes for the treatment of human diseases

Soo Rin Kim, Ja Kyong Ko, Kyeongnam Kim, Hwang Ju Jeon, Sung Eun Lee

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Scopus citations

Abstract

Lignin is a biopolymer by-product of cellulosic waste in the paper and renewable fuel industries and can be a cheap raw material for producing high-value-added materials. These value-added products can be used in various industries, such as agriculture, food materials, fine chemicals, animal husbandry, and cosmetics. Recently, various properties of lignin and its derivatives have been explored to develop drugs for the treatment of human diseases, including microbial and viral infection, oxidative stress, metabolic disorders, and cancers. For this regard, advanced techniques are introduced to degrade lignin properly into monomers to express high selectivity for securing human diseases by the composition of the monomers. In this review, we will introduce new applications of lignin and its derivatives in pharmaceutics as a result of its prominent biological activities by selectively cleaving or modifying the lignin polymer.

Original languageEnglish
Title of host publicationBiomass, Biofuels, Biochemicals
Subtitle of host publicationLignin Biorefinery
PublisherElsevier
Pages15-32
Number of pages18
ISBN (Electronic)9780128202944
ISBN (Print)9780128202968
DOIs
StatePublished - 1 Jan 2021

Keywords

  • Biorefinery
  • Human diseases
  • Lignin
  • Metabolic disorders
  • Pharmaceutics

Fingerprint

Dive into the research topics of 'Lignins and their close derivatives produced by biorefinery processes for the treatment of human diseases'. Together they form a unique fingerprint.

Cite this